Dr. Allison Walsh Kurian M.D.?
Update this Profile
Dr. Allison Walsh Kurian M.D., Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Allison Walsh Kurian M.D.

Hematologist-Oncologist | Hematology & Oncology

875 Blake Wilbur Dr Palo Alto CA, 94304

About

Dr. Allison Kurian is a hematologist oncologist practicing in Palo Alto, CA. Dr. Kurian specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Education and Training

Harvard Medical School 1999

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2005

Provider Details

FemaleEnglish 19 years of experience

Expert Publications

Data provided by the National Library of Medicine

Awards

  • California Breast Cancer Research Program 2010 Translational Research Award 
  • Robert Wood Johnson Foundation 2008 Physician Faculty Scholars Award 
  • American Society of Clinical Oncology 2005 Young Investigator Award 
  • Cancer Research and Prevention Foundation 2005 Fellowship Award 
  • California Breast Cancer Research Program 2005 Fellowship Award 
  • American Society of Clinical Oncology 2004 Merit Award 
  • California Breast Cancer Research Program 2007 Cornelius L. Hopper Research Abstract Award 
  • National Institutes of Health 2006 BIRCWH K12 Scholar Award 
  •  2011 Top 12 publications funded by the Epidemiology and Genomics Research 
  • Stanford University Cancer Institute 2013 Suzanne Pride Bryan Award for Breast Cancer Research 
  • Stanford University Cancer Institute 2011 New Clinical Investigator Award 
  • Stanford University Cancer Institute 2008 Jan Weimer Faculty Chair for Breast Oncology 

Treatments

  • Breast Cancer, Cancer Genetics
  • Breast Cancer
  • Ovarian Cancer

Fellowships

  • Stanford University School of Medicine CA    2005
  • Stanford University School of Medicine,Stanford, Ca, United States   2005

Publications

  • Jourl of clinical oncology : official jourl of the American Society ofClinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment.0
  • JOURL OF CLINICAL ONCOLOGYOnline Tool to Guide Decisions for BRCA1/2 Mutation Carriers2012
  • AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA SymposiumOncoshare: lessons learned from building an integrated multi2012
  • JOURL OF CLINICAL ONCOLOGYBreast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2011
  • JOURL OF CLINICAL ONCOLOGYSurvival Alysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers2010
  • JOURL OF THE TIOL CANCER INSTITUTESecond Primary Breast Cancer Occurrence According to Hormone Receptor Status2009
  • JOURL OF CLINICAL ONCOLOGYPerformance of BRCA1/2 mutation prediction models in Asian Americans2008
  • JOURL OF CLINICAL ONCOLOGYA cost-effectiveness alysis of adjuvant trastuzumab regimens in early HER22007
  • JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONCost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonce imaging2006
  • AMERICAN JOURL OF EPIDEMIOLOGYObesity and Mortality After Breast Cancer by Race2014
  • Jourl of the tiol Comprehensive Cancer NetworkA young woman with bilateral breast cancer2013
  • JOURL OF ONCOLOGY PRACTICEInformation technology interventions to improve cancer care2013
  • JOURL OF ADOLESCENT AND YOUNG ADULT ONCOLOGYA Population-Based Observatiol Study of First2013
  • JOURL OF THE TIOL CANCER INSTITUTEAge-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover2012
  • PLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
  • WORLD JOURL OF SURGERYAccuracy of BRCA1/2 Mutation Prediction Models2012
  • JOURL OF CLINICAL ONCOLOGYIn reply to Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2012
  • ANLS OF SURGICAL ONCOLOGYA Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer2011
  • BREAST CANCER RESEARCH AND TREATMENTHigh-resolution melting alysis for rapid screening of BRCA2 founder mutations in Southern Chinese2010
  • Jourl of the tiol Comprehensive Cancer NetworkGenetic/familial high-risk assessment: breast and ovarian.2010
  • JOURL OF CLINICAL ONCOLOGYIncreasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California2010
  • JOURL OF CLINICAL ONCOLOGYIn reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al2009
  • CURRENT ONCOLOGY REPORTSThe Decline in Breast Cancer Incidence: Real or Imagiry?2009
  • BREAST JOURLMagnetic resonce galactography2008
  • ANLS OF SURGERYCDH1 truncating mutations in the E-cadherin gene2007
  • BREAST JOURLDuctal pattern enhancement on magnetic resonce imaging of the breast due to ductal lavage2007
  • CANCERBreast magnetic resonce image screening2004
  • CancerBreast cancer treatment across health care systems2014
  • Journal of clinical oncology : official journal of the American SocietClinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment.0
  • BREAST CANCER RESEARCH AND TREATMENTPatterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California2013
  • JOURNAL OF CLINICAL ONCOLOGYOnline Tool to Guide Decisions for BRCA1/2 Mutation Carriers2012
  • AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA SymposiumOncoshare: lessons learned from building an integrated multi2012
  • JOURNAL OF CLINICAL ONCOLOGYBreast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2011
  • JOURNAL OF CLINICAL ONCOLOGYSurvival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers2010
  • BREAST CANCER RESEARCHLifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups2010
  • JOURNAL OF THE NATIONAL CANCER INSTITUTESecond Primary Breast Cancer Occurrence According to Hormone Receptor Status2009
  • JOURNAL OF CLINICAL ONCOLOGYPerformance of BRCA1/2 mutation prediction models in Asian Americans2008
  • JOURNAL OF CLINICAL ONCOLOGYA cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER22007
  • JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONCost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging2006
  • GYNECOLOGIC ONCOLOGYHistologic types of epithelial ovarian cancer: have they different risk factors?2005
  • AMERICAN JOURNAL OF EPIDEMIOLOGYObesity and Mortality After Breast Cancer by Race2014
  • RadiologyResponse.2014
  • CANCER CAUSES & CONTROLThe California Breast Cancer Survivorship Consortium (CBCSC)2013
  • Journal of the National Comprehensive Cancer NetworkA young woman with bilateral breast cancer2013
  • FAMILIAL CANCERFeasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers2013
  • RADIOLOGYThe California Breast Density Information Group0
  • JOURNAL OF ONCOLOGY PRACTICEInformation technology interventions to improve cancer care2013
  • BREAST CANCER RESEARCH AND TREATMENTA clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk2013
  • BREAST CANCER RESEARCHImpact of breast cancer subtypes on three-year survival among adolescent and young adult women2013
  • JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGYA Population-Based Observational Study of First2013
  • BREAST CANCER RESEARCH AND TREATMENTNovel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients2012
  • PLOS ONEIdentification of BRCA12012
  • FAMILIAL CANCERBreast cancer risk factors differ between Asian and white women with BRCA1/2 mutations2012
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONA Simulation Model to Predict the Impact of Prophylactic Surgery2012
  • JOURNAL OF THE NATIONAL CANCER INSTITUTEAge-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover2012
  • PLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONPatient, Hospital, and Neighborhood Factors Associated with Treatment of Early2012
  • WORLD JOURNAL OF SURGERYAccuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in2012
  • JOURNAL OF CLINICAL ONCOLOGYIn reply to Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2012
  • CURRENT BREAST CANCER REPORTSGenetic Polymorphisms as Predictors of Breast Cancer Risk2012
  • BREAST CANCER RESEARCHOccurrence of breast cancer subtypes in adolescent and young adult women2012
  • ANNALS OF SURGICAL ONCOLOGYA Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer2011
  • BREAST CANCER RESEARCH AND TREATMENTAsian ethnicity and breast cancer subtypes: a study from the California Cancer Registry2011
  • CONTEMPORARY OBSTETRICS AND GYNECOLOGYHereditary cancer: counseling women at risk2011
  • BREAST CANCER RESEARCH AND TREATMENTHigh-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese2010
  • Journal of the National Comprehensive Cancer NetworkGenetic/familial high-risk assessment: breast and ovarian.2010
  • JOURNAL OF CLINICAL ONCOLOGYIncreasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California2010
  • CURRENT OPINION IN OBSTETRICS & GYNECOLOGYBRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications2010
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONPerformance of Prediction Models for BRCA Mutation Carriage in Three Racial2009
  • JOURNAL OF CLINICAL ONCOLOGYIn reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al2009
  • CURRENT ONCOLOGY REPORTSThe Decline in Breast Cancer Incidence: Real or Imaginary?2009
  • Current breast cancer reportsStatins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease.2009
  • FAMILIAL CANCERCancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers2008
  • BREAST JOURNALMagnetic resonance galactography2008
  • CANCER GENETICS AND CYTOGENETICSA carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature2007
  • ANNALS OF SURGERYCDH1 truncating mutations in the E-cadherin gene2007
  • BREAST JOURNALDuctal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage2007
  • APPLIED PHYSICS LETTERSBiomedical terahertz imaging with a quantum cascade laser2006
  • HEALTH EXPECTATIONSOpinions of women with high inherited breast cancer risk about prophylactic mastectomy2005
  • CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONDuctal lavage of fluid-yielding and non2005
  • CANCERBreast magnetic resonance image screening2004

Experience & Accolades

  • Assistant Professor of Medicine (Oncology) and of Health Research and the Stanford University Medical Center
  • Member Scientific Program Committee, Cancer Prevention and Epidemiology
  • Member2011 - 2014 American Society of Clinical Oncology
  • Member Scientific Program Committee, Genetic and Molecular Epidemiology
  • Member Program Committee, Professional Development
  • Member2008 - 2011 American Society of Clinical Oncology
  • Member2008 - 2011 Career Development Subcommittee, American Society of Clinical Oncology
  • Member2012 - 2015 American Society of Clinical Oncology
  • Member2011 - 2012 American Association for Cancer Research
  • Member Track Leader, Cancer Prevention and Epidemiology, Scientific Program Committee
  • Member2013 - 2014 American Society of Clinical Oncology
  • Member Oncology Consultant, Breast Cancer Working Group, Cancer Intervention and Surveillance Modeling Net
  • Member2014 - 2014 National Cancer Institute
  • Member Scientific Program Committee, Quality Care Symposium
  • Director 2013 - 2014 Cancer Education Seminar, Stanford Division of Oncology
  • Member2013 - 2014 Panel on Clinical Guidelines Development for Breast Cancer Risk Reduction, National Comprehensive C
  • Member2012 - 2014 Advisory Committee, California HealthCare Foundation
  • Member2011 - 2014 Board of Directors, Santa Clara County, American Cancer Society
  • Member2009 - 2014 Panel on Clinical Guidelines Development for Genetic/ Familial Risk: Breast and Ovarian Cancer, Nat
  • Associate Director 2007 - 2014 Stanford Clinical Cancer Genetics Program
  • Associate Member2014 - 2014 Canary Center at Stanford for Cancer Early Detection

Dr. Allison Walsh Kurian M.D.'s Practice location

Practice At 875 Blake Wilbur Dr

875 Blake Wilbur Dr -
Palo Alto, CA 94304
Get Direction
New patients: 510-752-1000, 650-723-7621, 650-725-5544
Fax: 650-498-5150, 650-498-5346

Dr. Allison Walsh Kurian M.D.'s reviews

(0)
Write Review

Recommended Articles

  • What are the Stages of Multiple Myeloma?

    This is the uncommon type of cancer that forms in plasma cells. A type of white blood cells found in the body, plasma cells, identify and battle germs and infections that attack the body.In multiple myeloma patients, the healthy plasma cells are overtaken by cancer cells. This reduces the number of...

  • How Dogs Are Helping with Lymphoma Research

    According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...

  • Superheroes Unite For Elementary Student Fighting Lymphoma

    Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...

  • Potential Causes of Leukopenia

    IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...

  • The Effect of Sunshine on Lymphoma

    Having a lack of enough vitamin D can drastically effect one's ability to fight many cancers, including lymphoma. So, researchers inevitably wondered whether the addition of Vitamin D to preexisting therapies would prolong patients' lives. The Wilmot Cancer Institute received a $3 million grant for...

  • Inspirational Blood Cancer Survivors

    Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...

Nearby Providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head north on Blake Wilbur Drive 440 ft
Turn left onto Welch Road 1270 ft
Turn left onto Pasteur Drive 55 ft
You have arrived at your destination, on the left

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head north on Blake Wilbur Drive 413 ft
Turn right onto Welch Road 1607 ft
Turn left onto Quarry Road 1048 ft
Turn right onto Arboretum Road 1357 ft
Turn left onto Palm Drive 1622 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head north on Blake Wilbur Drive 413 ft
Turn right onto Welch Road 788 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left